ArticleJournal of hepatocellular carcinoma2026
NLR-PALBI Score and Its Grading: Predicting Overall Survival of Patients with Primary Liver Cancer Undergoing Transcatheter Arterial Chemoembolisation.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transcatheter arterial chemoembolisation (TACE) is the main first-line treatment regimen for advanced unresectable primary liver cancer (PLC), yet there is significant heterogeneity in patient prognosis. The postoperative platelet-albumin-bilirubin (PALBI) score can assess liver reserve function, and the neutrophil-to-lymphocyte ratio (NLR) reflects systemic inflammatory status. At present, there are insufficient studies on the predictive value of the combined NLR-PALBI score and its grading for overall survival (OS) in PLC patients after TACE. Aim of the Study: To investigate the prognostic performance of postoperative NLR-PALBI score and grading for OS in PLC patients treated with TACE. Patients and Methods: This was a retrospective cohort study enrolling 112 PLC patients who received TACE in our hospital from March 2017 to October 2019 and met the inclusion and exclusion criteria. Among them, 97 were male (86.61%) and 15 were female (13.39%), with a mean age of 54.26 years. The optimal cut-off values of postoperative NLR (6.97) and PALBI score (-1.65) were determined via receiver operating characteristic (ROC) curve, and the NLR-PALBI score and grading system (Grade I: 0 points, Grade II: 1 point, Grade III: 2 points) were constructed. ROC curve, Kaplan-Meier survival analysis and Cox proportional hazards regression model were applied to evaluate the prognostic value of each indicator and screen independent influencing factors of OS. Results: ROC curve analysis showed that the NLR-PALBI score had an AUC of 0.776, which was significantly higher than that of single NLR (AUC=0.741) and PALBI score (AUC=0.709) (P<0.01), with a sensitivity of 66.7% and a specificity of 89.1%. Multivariate Cox regression analysis confirmed that postoperative NLR (HR=1.573, 95% CI 1.011-2.446, P=0.005) and NLR-PALBI score (HR=1.656, 95% CI 1.398-1.961, P=0.044) were independent risk factors for poor prognosis in PLC patients. Kaplan-Meier analysis revealed that patients with NLR-PALBI Grade III had the shortest OS, with 1-year, 3-year and 5-year OS rates of 71.43%, 4.76% and 0%, respectively (P<0.01). Conclusion: Both postoperative NLR and NLR-PALBI score are independent risk factors for OS in PLC patients treated with TACE. The NLR-PALBI score has superior prognostic predictive value to single indicators, and patients with NLR-PALBI Grade III have the worst prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.